Based on these findings, telmisartan inhibited cell proliferation during TPA stimulation by specifically blocking nuclear translocation of HB-EGF-CTF AT1R-independently and nuclear transport of PLZF in colon cancer cells. Here, ZBTB16 is linked to colonic neoplasm.